CDT CDT Equity Inc.
$0.08▼ -14.89%
Healthcare
Other
After hours
$0.09▲ +8.88%
Oct 27, 5:58 PM ET
Volume 4.87M
Avg Volume (10D) 5.73M
Key Metrics & Fundamentals
Market Cap
$89,961
P/E Ratio
0.0
Div Yield
0.00%
52W Range
0.08 - 20125.00
% vs 50 MA
-99.49%
% vs 200 MA
-100.00%
RSI-14
15.0
MACD Histogram
+1.5600
Beta (1Y vs SPY)
1.51
Free Cash Flow
-$544,000
Gross Rev
$0
Gross Profit
$0
EBITDA
-$3.08M
COGS
–
Operating Exp
$3.00M
Operating Income
-$3.00M
EBIT
-$3.00M
Pretax Income
-$4.64M
Net Income
-$4.64M
EPS (Diluted)
-87.10
Price & Volume History
Loading chart…
Recent News
CDT Partners with Manoira to Explore Enhancing Animal Health Products Ahead of Launch
GlobeNewswire · Oct 27, 2026 8:00 AM ET
CDT Highlights Sarborg's Solid-Form Patent Filing on a First-in-Class Respiratory Asset
GlobeNewswire · Oct 14, 2026 8:10 AM ET
CDT Highlights Sarborg’s Expanding Quantum Computing IP Portfolio and Application to Drug Discovery
GlobeNewswire · Sep 29, 2026 7:00 AM ET
CDT Equity Inc. Announces Reverse Stock Split
GlobeNewswire · Sep 25, 2026 8:10 AM ET
CDT Partners with QIMA Life Sciences to Evaluate Novel Tapinarof Combinations in Psoriasis and Vitiligo
GlobeNewswire · Sep 18, 2026 6:30 AM ET
CDT Highlights Sarborg’s Application of Signature Intelligence and Quantum Computing Models to Mental Health
GlobeNewswire · Sep 10, 2026 7:00 AM ET
CDT Provides Capital Update and Confirms No Nasdaq Deficiencies
GlobeNewswire · Sep 2, 2026 5:00 AM ET
CDT Appoints Co-Founder James Bligh as Chief Executive Officer to Lead Next Phase of Growth
GlobeNewswire · Sep 1, 2026 8:00 AM ET
CDT Validates Enhanced Solid-Form Properties Within Its IP Portfolio
GlobeNewswire · Aug 28, 2026 5:00 AM ET
CDT Announces Investment in Pep'd, Expanding into the Fast-Growing US Peptide Market
GlobeNewswire · Aug 25, 2026 5:00 AM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See CDT's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.